Long  ||| S:0 E:5 ||| JJ
term  ||| S:5 E:10 ||| NN
groups  ||| S:10 E:17 ||| NNS
for  ||| S:17 E:21 ||| IN
patients  ||| S:21 E:30 ||| NNS
with  ||| S:30 E:35 ||| IN
psychosis  ||| S:35 E:45 ||| NN
in  ||| S:45 E:48 ||| IN
partial  ||| S:48 E:56 ||| JJ
remission  ||| S:56 E:66 ||| NN
-  ||| S:66 E:68 ||| :
evaluation  ||| S:68 E:79 ||| NN
of  ||| S:79 E:82 ||| IN
ten  ||| S:82 E:86 ||| JJ
years ||| S:86 E:91 ||| NNS
'  ||| S:91 E:93 ||| POS
work  ||| S:93 E:98 ||| NN
Outpatients  ||| S:98 E:110 ||| NNS
with  ||| S:110 E:115 ||| IN
psychosis  ||| S:115 E:125 ||| NNS
who  ||| S:125 E:129 ||| WP
attended  ||| S:129 E:138 ||| VBD
long  ||| S:138 E:143 ||| JJ
term  ||| S:143 E:148 ||| NN
psychotherapeutic  ||| S:148 E:166 ||| NN
groups  ||| S:166 E:173 ||| NNS
were  ||| S:173 E:178 ||| VBD
evaluated  ||| S:178 E:188 ||| VBN
regarding  ||| S:188 E:198 ||| VBG
their  ||| S:198 E:204 ||| PRP$
quality  ||| S:204 E:212 ||| NN
of  ||| S:212 E:215 ||| IN
life  ||| S:215 E:220 ||| NN
and  ||| S:220 E:224 ||| CC
attitude  ||| S:224 E:233 ||| NN
towards  ||| S:233 E:241 ||| IN
medication  ||| S:241 E:252 ||| NN
with  ||| S:252 E:257 ||| IN
self-report  ||| S:257 E:269 ||| JJ
questionnaires ||| S:269 E:283 ||| NN
.  ||| S:283 E:285 ||| .
The  ||| S:285 E:289 ||| DT
DAI-10 ||| S:289 E:295 ||| NNP
,  ||| S:295 E:297 ||| ,
Quality  ||| S:297 E:305 ||| NNP
of  ||| S:305 E:308 ||| IN
life  ||| S:308 E:313 ||| NN
Brief  ||| S:313 E:319 ||| NN
questionnaires  ||| S:319 E:334 ||| NNS
and  ||| S:334 E:338 ||| CC
clinical  ||| S:338 E:347 ||| JJ
observation  ||| S:347 E:359 ||| NN
were  ||| S:359 E:364 ||| VBD
used  ||| S:364 E:369 ||| VBN
for  ||| S:369 E:373 ||| IN
evaluation ||| S:373 E:383 ||| NN
.  ||| S:383 E:385 ||| .
Most  ||| S:385 E:390 ||| JJS
of  ||| S:390 E:393 ||| IN
the  ||| S:393 E:397 ||| DT
patients ||| S:397 E:405 ||| NNS
'  ||| S:405 E:407 ||| POS
participation  ||| S:407 E:421 ||| NN
in  ||| S:421 E:424 ||| IN
group  ||| S:424 E:430 ||| NN
therapy  ||| S:430 E:438 ||| NN
was  ||| S:438 E:442 ||| VBD
rated  ||| S:442 E:448 ||| VBN
as  ||| S:448 E:451 ||| IN
satisfactory  ||| S:451 E:464 ||| JJ
or  ||| S:464 E:467 ||| CC
very  ||| S:467 E:472 ||| RB
productive  ||| S:472 E:483 ||| JJ
by  ||| S:483 E:486 ||| IN
their  ||| S:486 E:492 ||| PRP$
group  ||| S:492 E:498 ||| NN
therapist ||| S:498 E:507 ||| NN
.  ||| S:507 E:509 ||| .
More  ||| S:509 E:514 ||| RBR
than  ||| S:514 E:519 ||| IN
half  ||| S:519 E:524 ||| NN
of  ||| S:524 E:527 ||| IN
our  ||| S:527 E:531 ||| PRP$
patients  ||| S:531 E:540 ||| NNS
rated  ||| S:540 E:546 ||| VBN
the  ||| S:546 E:550 ||| DT
group  ||| S:550 E:556 ||| NN
therapy ||| S:556 E:563 ||| NN
's  ||| S:563 E:566 ||| POS
influence  ||| S:566 E:576 ||| NN
on  ||| S:576 E:579 ||| IN
their  ||| S:579 E:585 ||| PRP$
life  ||| S:585 E:590 ||| NN
as  ||| S:590 E:593 ||| IN
important ||| S:593 E:602 ||| JJ
;  ||| S:602 E:604 ||| :
only  ||| S:604 E:609 ||| RB
three  ||| S:609 E:615 ||| CD
of  ||| S:615 E:618 ||| IN
them  ||| S:618 E:623 ||| PRP
noticed  ||| S:623 E:631 ||| VBD
no  ||| S:631 E:634 ||| DT
importance  ||| S:634 E:645 ||| NN
of  ||| S:645 E:648 ||| IN
the  ||| S:648 E:652 ||| DT
group  ||| S:652 E:658 ||| NN
therapy  ||| S:658 E:666 ||| NN
on  ||| S:666 E:669 ||| IN
their  ||| S:669 E:675 ||| PRP$
life ||| S:675 E:679 ||| NN
.  ||| S:679 E:681 ||| .
The  ||| S:681 E:685 ||| DT
sample  ||| S:685 E:692 ||| NN
may  ||| S:692 E:696 ||| MD
be  ||| S:696 E:699 ||| VB
too  ||| S:699 E:703 ||| RB
small  ||| S:703 E:709 ||| JJ
to  ||| S:709 E:712 ||| TO
show  ||| S:712 E:717 ||| VB
a  ||| S:717 E:719 ||| DT
statistically  ||| S:719 E:733 ||| JJ
significant  ||| S:733 E:745 ||| JJ
correlation  ||| S:745 E:757 ||| NN
between  ||| S:757 E:765 ||| IN
participation  ||| S:765 E:779 ||| NN
in  ||| S:779 E:782 ||| IN
the  ||| S:782 E:786 ||| DT
group  ||| S:786 E:792 ||| NN
and  ||| S:792 E:796 ||| CC
time  ||| S:796 E:801 ||| NN
spent  ||| S:801 E:807 ||| VBD
in  ||| S:807 E:810 ||| IN
group  ||| S:810 E:816 ||| NN
therapy  ||| S:816 E:824 ||| NN
and  ||| S:824 E:828 ||| CC
attitude  ||| S:828 E:837 ||| NN
towards  ||| S:837 E:845 ||| IN
medication ||| S:845 E:855 ||| NN
.  ||| S:855 E:857 ||| .
